Phio Pharmaceuticals implements 1-for-9 reverse stock split effective July 5, 2024

Phio Pharmaceuticals Corp.

Reverse split ratio set at 1-for-9; reduces outstanding shares from ~4.6M to ~0.5M.
Split effective 12:01 a.m. ET on July 5, 2024; trading symbol remains PHIO.
Adopted to meet Nasdaq minimum $1.00 bid price requirement for continued listing.
No fractional shares issued; cash payment in lieu for fractional holdings.
CUSIP changed to 71880W501; transfer agent Computershare managing exchange.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.